FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to development of new complex agent based on interferon with antioxidant complex applied for infection-inflammatory diseases of patients suffering from allergic diseases including pregnant women and newborns. Agent additionally contains calcium salts characterised by antiallergenic, hyposensitising action.
EFFECT: invention provides decreased risk of allergic reaction for components of complex treatment of infection-inflammatory diseases.
6 cl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| MEDICINE WITH IMMUNE MODIFYING, ANTIVIRUS, ANTIBACTERIAL ANTIOXIDISING, MEMBRANE STABILISING, CARTILAGE AND CONNECTIVE TISSUE GROWTH STIMULATING EFFECT | 2007 |
|
RU2349339C1 |
| PHARAMCEUTICAL AGENT FOR TREATMENT OF VIRAL AND DIFFERENT INFECTIONS | 2006 |
|
RU2323738C1 |
| PROLONGED INTERFERON SOLUTION | 2004 |
|
RU2270692C1 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| RECTAL SUPPOSITORY MEDICINAL PRODUCT AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2689320C1 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
